Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat
Condition(s):Central Abdominal BulgingLast Updated:January 8, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Central Abdominal BulgingLast Updated:January 8, 2016Completed
Condition(s):NeuroblastomaLast Updated:December 6, 2023Completed
Condition(s):Acne VulgarisLast Updated:June 16, 2016Unknown status
Condition(s):Crohn DiseaseLast Updated:November 16, 2022Completed
Condition(s):Chronic Idiopathic ConstipationLast Updated:November 7, 2017Completed
Condition(s):WartsLast Updated:June 4, 2019Completed
Condition(s):Cystic FibrosisLast Updated:June 12, 2018Completed
Condition(s):Coronary Artery Disease; Atherosclerosis, Coronary; Myocardial Ischemia; Ischemic Heart Disease; Acute Coronary Syndrome; Angina PectorisLast Updated:August 3, 2022Completed
Condition(s):MelanomaLast Updated:January 10, 2024Active, not recruiting
Condition(s):Chronic Graft Versus Host DiseaseLast Updated:March 26, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.